ArticleApplied biochemistry and biotechnology2026
Antibiofilm Activity of Allicin and Quercetin in Treating Biofilm-Associated Orthopaedics Infection.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Anti-QS Strategies AgainstMicroorganisms · 2025Review
- Inhibitory Effects of Lactobionic Acid on Biofilm Formation and Virulence ofFoods (Basel, Switzerland) · 2024Article
- A review on antimicrobial strategies in mitigating biofilm-associated infections on medical implants.Current research in microbial sciences · 2024Review
- Comparative metabolite profiling of four polyphenol rich Morus leaves extracts in relation to their antibiofilm activity against Enterococcus faecalis.Scientific reports · 2022Article
- Chemical Composition and Agronomic Traits ofFoods (Basel, Switzerland) · 2022Article
- Recent advances to combat ESKAPE pathogens with special reference to essential oils.Frontiers in microbiology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biofilms formed by bacteria are the group of sessile microbial cells that remain encompassed by self-secreted polymeric substances and have resulted in great health-care concern. The extracellular polymeric substances (EPS) prevent the penetration of antibiotics and other drugs, thereby resulting in the development of multi-drug resistance or antibiotic resistance. The biofilm-associated prosthetics being places at the joins of bone injury are the common sites for the development of biofilm-associated infection. This often spreads and results in the development of orthopaedic infections. Most of the infections are associated with musculoskeletal system and originate from non-living surfaces. The biofilm prevents the penetration of drugs, thereby resulting in the development of antibiotic resistance or multi-drug resistance. The minimum inhibitory concentration (MIC) for allicin and quercetin was found to be 80 µg/mL for quercetin and 100 µg/mL for amoxicillin against the sessile communities of Pseudomonas aeruginosa associated with the orthopaedic infection. The role of quercetin and allicin in reduction of protein, carbohydrate and eDNA content of the exopolysaccharides (EPS) was tested. The anti-quorum sensing activity of quercetin and allicin was confirmed both by biochemical and by photomicrographic studies. The antibiofilm and antimicrobial activities of quercetin and allicin were determined both by in vitro and in silico studies on P. aeruginosa bacterial strain from biofilm-associated orthopaedic infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.